Journal
STEM CELLS AND DEVELOPMENT
Volume 21, Issue 13, Pages 2552-2559Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/scd.2012.0092
Keywords
-
Funding
- National Institutes of Health [DK045370, DK64538, DK069655]
Ask authors/readers for more resources
Thymidine analog 5-ethynyl-2'-deoxyuridirie (EdU) has recently been introduced as an alternative to 5-bromo-2-deoxyuridine (BrdU) for cell labeling and tracking. Incorporation of EdU into replicating DNA can be detected by azide-conjugated fluors (eg, Alexa-azide) through a Cu(i)-catalyzed click reaction between EdU's alkyne moiety and azide. While this cell labeling method has proven to be valuable for tracking transplanted stem cells in various tissues, we have found that some bone marrow cells could be stained by Alexa-azide in the absence of EdU label. In intact rat femoral bone marrow, similar to 3% of nucleated cells were false-positively stained, and in isolated bone marrow cells, similar to 13%. In contrast to true-positive stains, which localize in the nucleus, the false-positive stains were cytoplasmic. Furthermore, while true-positive staining requires Cu(i), false-positive staining does not. Reducing the click reaction time or reducing the Alexa-azide concentration failed to improve the distinction between true- and false-positive staining. Hematopoietic and mesenchymal stem cell markers CD34 and Stro-1 did not co-localize with the false-positively stained cells, and these cells' identity remains unknown.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available